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Introduction and objective 
 
   In 1922, tocopherol was discovered in green leafy vegetables as a micronutrient 
essential for reproduction [1].  More than 40 years l ter, tocotrienol was isolated from 
latex [2].  Structurally, these vitamin E differ only in their side chains (Fig. 1).  Toc 
has saturated phytyl side chain, while T3 contains unsaturated isoprenoid tail.  To date, 
eight substances have been found in nature as vitamin E: α-, β-, γ-, and δ-Toc and α-, β-, 
γ-, and δ-T3.  Vitamin E is synthesized in plastids of plants, and Toc is widely present 
in a variety of foods such as vegetable oils and nuts.  But, T3-containing foods are 
limited.  Rice bran, palm oil, and annatto seed are rich in T3 [3]. 
    Toc and T3 are classified based on their ability (vitamin E activity) to prevent the 
resorption of rat fetuses.  α-Toc displays the highest efficacy among the eight vitamin 
E, whereas α-T3 has about one third of the activity of α-Toc.  Regardless, all forms of 
vitamin E are able to induce antioxidative effects and to act as protective agents against 
lipid peroxidation in biological membranes.  In some odel membrane studies, T3 has 
been reported to be a more potent antioxidant than Toc [4].  Moreover, T3 has recently 
gained increasing interest due to its several healt-promoting properties that differ 
somewhat from those of Toc.  For example, T3 protects neuronal cells against 
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oxidative damage [5], and suppresses pathological angiogenesis [6,7] and cancer [8].  
These unique effects of T3 could be partly explained by its abilities to induce cell cycle 
arrest [9], to activate p53 and caspase [10,11], to suppress adhesion molecules [12], to 
inhibit nuclear factor-κB [13], and to down-regulate c-Myc and telomerase [14]. 
    Besides the above activities [5-14], T3 has also gained much attention for its 
lipid-lowering properties, especially reduction of cholesterol (Cho).  The Cho-lowering 
effects have been observed in cell culture [15-17], animal [18-21], and human studies 
[22], and the mechanism may involve a repression of hepatic 
3-hydroxy-3-methylglutaryl-coenzyme A reductase (HMG-CoAR) through a 
post-transcriptional process [15,16].  However, it should be noted that several research 
groups failed to observe significant changes in serum Cho profiles after 
supplementation of T3 to hypercholesterolemic patients [23-25] and hyperlipidemic 
patients with carotid atherosclerosis [26].  Therefo , the effect of T3 on Cho is still 
controversial and needs further studies. 
    On the other hand, although little attention has been paid to whether T3 affects 
other lipids except for Cho, some earlier studies have suggested a usefulness of T3 in 
improving triglyceride (TG) profiles.  For instance, T3 supplementation has been 
reported to decrease serum TG levels in healthy human [27] and hypercholesterolemic 
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patients [28].  In support of these results, Zaiden et al. [29] recently reported an ability 
of T3 to reduce TG biosynthesis in human hepatoma cells (HepG2).  Therefore, these 
studies [27-29] raise a novel possibility that reduction of TG may be a primary role for 
the lipid-lowering properties of T3.  However, because there are few literatures that 
have evaluated the impact of T3 on TG at gene expression levels, further biological 
studies are needed to elucidate the mechanism(s) how T3 decreases TG. 
    In this study, we aimed to investigate how γ-T3 (most abundant isomer of rice bran 
T3, RBT3) suppresses TG levels by affecting TG-related gene expressions in normal 
and fat (oleic acid) loaded HepG2.  In high fat diet fed rats, the TG-lowering properties 
of RBT3 was further evaluated, and compared with Cho-lowering activity.  We 
confirmed that T3 attenuates TG accumulations by regulating fatty acid synthase 
(FASN), carnitine palmitoyltransferase 1 (CPT1A), and cytochrome P450 3A4 
 

























































Chapter 1: In vitro and in vivo attenuation of triglyceride accumulation by tocotrienol  
 
Part 1.  Attenuation of triglyceride accumulation by tocotrienol in HepG2 and F344 
rats 
 
1. Materials and Methods 
 
1.1 Reagents and Cells 
 
    α-T3 and γ-T3 were purchased from Chromadex (Santa Ana, CA, USA).  α-Toc 
was obtained from Sigma (St. Louis, MO, USA) and WST-1 reagent from Dojindo 
Laboratories (Kumamoto, Japan).  All other reagents were of analytical grade.  RBT3 
was kindly provided by Sanwa Yushi Co. Ltd. (Tendo, Yamagata, Japan).  RBT3 was 
composed of 82.3% T3 (31.4% α-T3, 50.5% γ-T3, and 0.4% δ-T3) and 6.0% Toc (1.9% 
α-Toc, 2.1% γ-Toc, and 2.0% δ-Toc) (w/w).  Vitamin E-stripped corn oil was 
purchased from Acros Organics (Fairlawn, NJ, USA). 
    HepG2 were obtained from the RIKEN cell bank (Tsukuba, Japan).  The cells 
were cultured in RPMI-1640 medium (containing 0.3 g/L L-glutamine and 2.0 g/L 
sodium bicarbonate, Sigma) supplemented with 10% fetal bovine serum (FBS; Biowest, 
Paris, France), 100 kU/L penicillin, and streptomycin (100 mg/L) (Gibco BRL 
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Rockville, MD, USA) at 37 °C in 5% CO2/95% air atmosphere in a humidified 
incubator. 
 
1.2 Preparation of Experimental Medium for Cell Culture Study 
 
    γ-T3 was dissolved in ethanol at a concentration of 50 µM.  The stock solution 
was diluted with either 1% bovine serum albumin (BSA; igma)/RPMI-1640 (control 
test medium) or 1% BSA/RPMI-1640 containing 1 mM oleic acid as fat-loaded medium 
[30] to achieve the desired final concentration of γ-T3 (0-50 µM).  The final 
concentration of ethanol in the experimental medium was less than 0.1% (v/v), which 
did not affect cell viability.  Medium with ethanol a one was similarly prepared and 
used as control medium. 
 
1.3 Cell Viability Assay 
     
    For cell viability assays, HepG2 (1 × 105) were pre-incubated with 10% 
FBS/RPMI-1640 in 96 well culture plates.  Twenty-four hours later, the cells were 
washed with PBS and medium was replaced with the exp rimental medium.  As for 
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the control condition, HepG2 were incubated in the experimental medium without oleic 
acid together with 0-50 µM γ-T3.  In fat-loaded condition, HepG2 were cultured with 
experimental medium containing 1 mM oleic acid (as fat-loaded medium) and γ-T3.  
After incubation for 24 h, the number of viable cells was determined using WST-1 
reagent according to the manufacturer’s instructions.  In brief, WST-1 reagent (10 µL) 
was added to the medium, and incubated at 37 °C for 3 h.  Absorbance (450/655 nm) 
of the medium was measured with a microplate reader (Model 550, Bio-Rad 
Laboratories, Inc., Hercules, CA, USA).  WST-1 is a tetrazolium salt that is converted 
into the soluble formazan salt by succinate-tetrazolium reductase of the respiratory 
chain of active mitochondria of viable cells [31]. 
 
1.4 TG Analysis 
 
    Cellular TG concentrations were evaluated using Folch method [32].  Briefly, 
HepG2 (1 × 105) were pre-incubated with 10% FBS/RPMI-1640 in a 35 mm cell culture 
plate for 24 h, and were cultured under control and f t-loaded conditions as described 
above.  After 24 h incubation, cells were washed with PBS and scrapped using rubber 
policeman, transferred into eppendorf tube (1.5 mL)and were centrifuged for 1,000g for 
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3 minutes.  Cell pellets were transferred to micro smashing tube with the addition of 
500 µL PBS buffer for homogenization.  After homogenization, contents of the cellular 
protein were determined using Bradford protein assay (Bio-Rad Laboratories) [33]. 
Cellular TG was extracted using Folch method and was measured using commercial TG 
kit (Wako, Osaka, Japan). 
 
1.5 Isolation of Total RNA and Analysis of mRNA Expression 
 
    After 24 h treatment of HepG2 (1 × 105) with the experimental medium, cells were 
lysed, scrapped with rubber police man, and transferred into a micro smashing tube.  
Total RNA was isolated with an RNeasy Plus Mini kit (Qiagen, Valencia, CA, USA) for 
real-time quantitative reverse transcription-PCR (RT-PCR).  cDNA was synthesized 
using a Ready-To-Go T-Primed First-Strand kit (GE Healthcare, Piscataway, NJ, USA), 
and PCR amplification was performed with a CFX96 Real-Time PCR Detection System 
(Bio-Rad Laboratories, New South Wales, Australia) using SYBR Premix Ex Taq 
(Takara Bio Inc., Shiga, Japan) and gene-specific primers for FASN, CPT1A, CYP3A4, 




1.6 Western Blotting Analysis 
 
    After HepG2 (1 × 105) both in control and fat-loaded conditions were incubated 
with test medium for 24 h, proteins were separated by SDS-PAGE (4-20% e-PAGEL; 
Atto, Tokyo, Japan).  The protein bands were transferred to polyvinylidene fluoride 
membranes (Invitrogen, Carlsbad, CA, USA).  After blocking for 1 h, membranes 
were incubated with primary antibodies for FASN, CPT1A, CYP3A4, and β-actin (Cell 
Signaling Technology, Beverly, MA, USA), followed by horseradish 
peroxidase-conjugated secondary antibody (Cell Signaling Technology).  ECL Plus 
(GE healthcare) was used for detection.  Bands intensiti s were measured using Image 
Lab software version 3.0 (BioRad, Hercules, CA, USA). 
 
1.7 Animal Experiment 
 
    Male F344 rats (6 weeks of age) were obtained from CLEA (Tokyo, Japan), and 
housed in cages kept at 23 °C with a 12 h light:dark cycle.  The rats were acclimated 
with MF rodent chow (5% of calories from fat; Oriental Yeast, Tokyo, Japan) and water 
for 1 week.  After acclimatization, rats received ad libitum either MF or high fat diet 
11 
 
(35% of calories from fat (powdered beef tallow 15%/100 g and high oleic acid 
safflower oil 20%/100 g), High Fat Diet HFD32, CLEA).  The high fat treated rats 
were fed with 5 mg of RBT3 (1.57 mg α-T3, 2.52 mg γ-T3, 0.02 mg δ-T3, 0.10 mg 
α-Toc, 0.11 mg γ-Toc, and 0.10 mg δ-Toc), 10 mg of RBT3 (3.14 mg α-T3, 5.04 mg 
γ-T3, 0.04 mg δ-T3, 0.19 mg α-Toc, 0.21 mg γ-Toc, and 0.20 mg δ-Toc), or 10 mg 
α-Toc once a day for 3 weeks by oral gavage using 200 µL vitamin E-stripped corn oil 
as a vehicle.  Positive (high fat diet treated) andnegative (MF rodent chow treated) 
control rats received only the vehicle (vitamin E-stripped corn oil).  During the feeding 
period, weight of rats and food intake were recorded.  At the end of the 3 week period, 
the rats were fasted for 12 h, weighed, and blood samples were collected by decapitation.  
Blood was treated with EDTA, and plasma was isolated by centrifugation at 1,000g for 
15 min at 4 °C.  Liver, heart, lung, spleen, kidney, and adipose tissues were removed 
and weighed.  These protocols were reviewed by the Committee on the Ethics of 
Animal Experiments and carried out in accordance with the Animal Experiment 






1.8 Hepatic and Plasma Parameters 
 
    Livers were homogenized in aqueous solution containing 1 mM EDTA and 0.09% 
NaCl.  The liver homogenates were then subjected to lipid extraction by Folch method 
[32].  Total lipid extracts were subjected to TG, total Cho (T-Cho), and phospholipid 
(PL) analyses using commercial kits (Wako). 
    For plasma samples, TG, T-Cho, and PL were measur d by Mitsubishi Chemical 
Medicine Corporation (Tokyo, Japan). 
 
1.9 Plasma and Liver Phospholipid Hydroperoxides 
 
    To examine oxidative stress, phospholipid hydrope xides (PLOOH) in total lipid 
extracts from plasma and liver were measured by HPLC with chemiluminescence (CL) 
detection [34, 35]. PLOOH is a collective term for phospholipid hydroperoxides such as 
phosphatidylcholine hydroperoxide (PCOOH) and phospatidylethanolamine 
hydroperoxide (PEOOH).  The column was a Finepak SIL NH2-5 (4.6 × 250 mm; 
Japan Spectroscopic Co., Tokyo, Japan), the eluent was 2-propanol-methanol-water 
(135:45:20, v/v/v), and the flow rate was 1 mL/min.  Post-column CL detection was 
13 
 
carried out using a CLD-100 detector (Tohoku Electronic Industries Co., Sendai, Japan).  
A mixture of luminol and cytochrome c in 50 mM borate buffer (pH 10.0) was used as a 
hydroperoxide-specific post-column CL reagent.  Calibr tion was carried out using 
standard PLOOH. 
 
1.10 Statistical Analysis 
 
    The data were expressed as the mean ± standard deviation (SD).  One-Way 
ANOVA was performed, followed by the Bonferroni/Dunn test for multiple 
comparisons.  Differences were considered significant at P < 0.05. 
 
1.11 Results and discussion 
 
1.11.1 Effect of γ-T3 on HepG2 Proliferation 
 
    In order to investigate whether T3 affects TG concentrations, increasing amount of 
γ-T3 was treated to HepG2 for 24 h in both control as well as fat-loaded conditions.  
Before investigating the effect on TG, cytotoxic activity of γ-T3 was first evaluated.  
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As for the control condition, HepG2 proliferation was somewhat increased by γ-T3 
treatment (1-5 µM), while 10-15 µM γ-T3 did not affect on the proliferation (Fig. 2A).  
As some papers have already reported [36], higher dose (over 15 µM) of γ-T3 showed 
cytotoxic effect (data not shown).  Similar effect of γ-T3 was observed under 
fat-loaded condition, although the condition showed a more increased proliferation than 
control condition (Fig. 2A).  Because 1-15 µM γ-T3 showed no cytotoxicity except for 
15 µM γ-T3 in fat-loaded condition showing little decrease of proliferation, we utilized 

























Fig. 2 Effect of increasing concentrations of γ-T3 on cell proliferation (A) and TG 
accumulation (B) of HepG2 in normal and fat overloaded conditions.  Experimental 
procedures are shown in Materials and Methods.  Data are expressed as mean ± SD (n 
= 6 for cell proliferation and n = 3 for TG accumulation).  Means without a common 
















































































































































































































































1.11.2 TG Accumulation is Attenuated with γ-T3 by Affecting Fatty Acid Synthase and 
β-Oxidation Genes and Proteins Expressions in HepG2 
 
    TG accumulation in HepG2 was evaluated by Folch method.  For control  
condition, 1-5 µM γ-T3 showed a little effect on TG concentrations (Fig. 2B), probably 
due to somewhat increase of the proliferation.  But, it was found that 10-15 µM γ-T3 
revealed a marked decrease of TG concentration.  For fat-loaded condition, 1-10 µM 
γ-T3 treated cells showed an increase in TG concentrations, whereas a significant 
decrease of TG was observed at 15 µM.  The reason why 1-10 µM γ-T3 
supplementation increases TG concentration may be due increased cell proliferation.  
These data clearly suggested the TG-lowering effect of T3, and we therefore 
investigated the effect of γ-T3 on TG-synthesis related gene (FASN) and β-oxidation 
genes (CPT1A and CYP3A4).  Significant down-regulation of FASN as well as 
up-regulation of CPT1A and CYP3A4 genes were observed by γ-T3 treatment (over 
about 10 µM) in both control and fat-loaded conditions (Fig. 3).  Similarly, γ-T3 
attenuated the expression of FASN protein and at the same time induced the expression 
of CPT1A and CYP3A4 proteins (Fig. 4).  Therefore, a possible mechanism of the 
TG-lowering effect of γ-T3 is mediated by down-regulation of FASN and up-regulation 
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Fig. 3 Effect of increasing concentrations of γ-T3 on mRNA expression of FASN, 
CPT1A, and CYP3A4 genes in HepG2 in normal and fat overloaded conditions.  
Experimental procedures are shown in Materials and Methods.  Data are expressed as 
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Fig. 4 Effect of increasing concentrations of γ-T3 on expression of FASN, CPT1A, and 
CYP3A4 proteins in HepG2 in normal and fat overloaded conditions.  Experimental 
procedures are shown in Materials and Methods.  Each Western blot is a representative 
example of data from three replicate experiments. 
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1.11.3 Dietary T3 Reduces TG and PLOOH accumulations in Liver and Plasma of 
Rats 
 
    To verify the TG-lowering effect of T3 in vivo, a rat study was conducted.  Rats 
received either control MF or high fat diet with or without RBT3 for 3 weeks.  High 
fat diet caused significant increase of the weight of rats, and the weight tended to 
decrease (P = 0.34) in 10 mg RBT3 group (Table 2).  RBT3 supplementation did not 
affect the weight of organs, but adipose tissues, especially epididymal and mesenteric 
fats, showed reduction of the weight in 10 mg RBT3 group (Table 1).  No differences 
were observed for food intake (data not shown).  For liver parameters, high fat diet 
caused significant accumulation of TG and tended to induce PL (P = 0.11) accumulation, 
and also showed a significant accumulation of PLOOH (oxidative stress marker) (Fig. 
5).  It was found that these accumulations, especially TG and PLOOH, were 
significantly attenuated by 10 mg RBT3 supplemented group (Fig. 5).  Similar results 
were observed for plasma (Fig. 6).  In contrast, no significant differences were 
observed for liver and plasma T-Cho.  For α-Toc supplemented group, no differences 
were found for lipids and PLOOH parameters in liver and plasma.  These results 
indicated that the main lipid lowering effects of dietary T3 might be mediated by the 
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Body weight Liver Heart Lung Spleen Kidney Perinephiric fat Mesenteric fat Epididymal fat
Control MF 192±9.3 6.54±0.62 0.70±0.07 0.83±0.08 0.47±0.03 1.26±0.10 2.50±0.65 2.24±0.49 2.81±0.82
High fat diet 213±10.5 6.40±0.60 0.71±0.04 1.01±0.14 0.46±0.05 1.34±0.08 4.93±0.95 3.77±0.43 4.46±0.92
5 mg RBT3 219±9.7 6.78±0.71 0.71±0.05 1.18±0.22 0.50±0.03 1.39±0.09 4.98±0.31 3.79±0.27 4.73±0.68
10 mg RBT3 206±15.3 6.19±0.54 0.67±0.05 0.88±0.19 0.46±0.02 1.30±0.11 3.73±0.65 2.97±0.30 3.93±0.60
































Fig. 5 Effect of RBT3 supplementation on liver lipids (TG, PL, and T-Cho) and 
oxidative parameter (PLOOH) of rats receiving contrl MF or high fat diet for 3 weeks.  
Experimental procedures are shown in Materials and Methods.  Because 
phosphatidylcholine hydroperoxide (PCOOH) and phospatidylethanolamin 
hydroperoxide (PEOOH) are major forms of PLOOH in liver [32, 33], PLOOH is 
calculated as sum of PCOOH and PEOOH.  Data are expressed as mean ± SD (n = 7).  




























































































































































































Fig. 6 Effect of RBT3 supplementation on plasma lipids (TG and PL) and oxidative 
parameter (PLOOH) of rats receiving control MF or high fat diet for 3 weeks.  
Experimental procedures are shown in Materials and Methods.  Because PCOOH is a 
major form of PLOOH in plasma [32, 33], PCOOH content is presented as PLOOH.  









    TG accumulation has been linked to cascade diffrent afflictions such as coronary 
artery diseases.  In addition, the involvement of oxidative stress (i.e., PCOOH 
formation) probably due to high TG concentration in vivo has been reported [37].  On 
the other hand, a novel possibility pertaining to the attenuating effect of T3 on TG 
accumulation has been published in some (but not many) studies [27-29].  Since the 
specific target of T3 in the lipogenic pathway is still vague, further biological studies are 
needed to elucidate the mechanism(s) on how T3 decreases TG.  In the present study, 
we confirmed TG-lowering effect of T3 in both in vivo and in vitro studies, and the 
effect of T3 could be partly explained by its ability to down-regulate hepatic fatty acid 
synthase gene and up-regulate β-oxidation genes.  These results support a hypothesis 
that reduction of TG may be the primary benefit caused by dietary T3 [29]. 
    In this study, similar to previous papers [36], higher dosage of γ-T3 (over 15 µM) 
caused cytotoxicity to HepG2 possibly due to apoptosis induction (Fig. 2A).  However, 
low dosage of γ-T3 (1-5 µM) somewhat increased HepG2 proliferation (Fig. 2A).  The 
reasons of the induced cellular proliferation still remain unknown, but such increased 
proliferation was found when cells were incubated with certain antioxidants such as 
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catechin [38].  Consequently, because 1-15 µM γ-T3 showed no obvious cytotoxicity, 
we utilized these γ-T3 concentrations in the next experiments for evaluating their effects 
on TG. 
    For TG concentration, addition of oleic acid as f t inducer showed around 1.5 fold 
increase of TG in HepG2 as compared to control conditi  (Fig. 2B).  Such increase 
was markedly attenuated by 15 µM γ-T3.  Similar effect was observed to its control 
condition counterpart.  To date, to the best of our knowledge, there has been one report 
focusing on the effect of T3 on TG in cell culture study.  Zaiden et al. [29] reported 
that treatment of γ-T3 and δ-T3 (each 20 µM) reduces TG synthesis and VLDL 
secretion in HepG2, however this study did not measure the actual TG content of the 
cells.  The present study provides quantitative TG results in the cells after 
administration of γ-T3, and significant attenuation of TG was observed at lesser 
concentrations of γ-T3 (15 µM). 
    In the present study, we provided new information regarding the possible 
mechanism of action of γ-T3 for its TG lowering property by down regulation f FASN 
and up regulation of CPT1A and CYP3A4 in both mRNA and protein levels (Figs. 3 
and 4).  Way et al. [39] showed that down regulation of FASN, key enzymes for 
lipogenesis by Puerh tea supplementation can attenua  lipid accumulation such as TG 
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in HepG2 cells.  On the other hand, β-oxidation genes such as CPT1A and CYP3A4 
have different interplaying roles in lipid metabolism.  For instance, CPT1A, 
rate-limiting enzyme for fatty acid oxidation in all tissues was up-regulated in HepG2 
upon consumption of polyunsaturated fatty acids, polyphenol and L-carnitine which led 
to reduced plasma lipid concentrations in human study [40].  Moreover, CYP3A4, one 
of the most important enzymes involved in the metabolism of xenobiotics in the body, 
has been reported to participate in lipid metabolism by regulation of 
25-hydroxycholesterol in mouse liver cells derived c ll line [41].  In support to these 
reports [39-41], administration of γ-T3 in HepG2 significantly down regulated FASN 
and up-regulated CPT1A and CYP3A4 genes thereby attenua ing TG accumulations 
(Figs. 2B and 3).  In addition, similar effects were observed in the protein expression 
of these genes (Fig. 4). 
    In support to cell culture study, 10 mg RBT3 diet significantly attenuated the 
accumulation of TG in both liver and plasma of rats (Figs. 5 and 6).  T3 has been 
reported to have a potent antioxidative effect [4].  High fat diet has been reported to 
increase oxidative stress and resulted in increase of plasma and liver PLOOH [37].  It 
is therefore conceivable that T3 can markedly reduc high fat diet-induced PLOOH 
accumulation in vivo (Figs. 5 and 6).  In contrast, dietary RBT3 failed to affect T-Cho 
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concentrations (Figs. 5 and 6).  Concerning the reported Cho lowering effect of T3,
Querishi et al. [42] actually demonstrated that the eff ct of T3 was attenuated by α-Toc.  
Therefore, the unchanged Cho levels may be due to the presence of α-Toc in the RBT3 
(around 0.6 mg for 10 mg RBT3) used in this study.  On the other hand, α-Toc did not 
show any attenuation of TG (Figs. 5 and 6).  In support to this peculiarity, a study 
published by Punithavathi et al. [43] showed no effect of α-Toc supplementation alone 
on TG in an isoproterenol-induced myocardial infarcted Wistar rats.  Moreover, our 
study [43] reported that α-Toc attenuated the cytotoxic effect of δ-T3 in human 
colorectal adenocarcinoma cells.  Present study may i plicate that among all vitamin 
E family isomers, a more detailed research between th  interactions of these isomers is 
of great interest.  In addition, since the amount of α-T3 present in RBT3 is 
considerably high, α-T3 was then subjected to proliferation and TG assays to remove 
the doubt that this T3 isomer might contributed in the TG attenuating effect of T3 (γ-T3). 
It was found out that α-T3 did not show any cytotoxicity nor attenuated the TG 
accumulations in HepG 2 cells (Supplementary figure 1).  Interestingly, 
supplementation of RBT3 (10 mg/day) as well as α-Toc showed significant reduction of 
the weight of both perinephric and epididymal fats of rats (Table 1), and therefore we 
now investigating the possible mechanism behind this interesting attenuating effect of 
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α-Toc on adipose tissue deposition. 
    The lipid biosynthesis has a broad array of interplaying genes in its pathway 
thereby a thorough testing of any possible genes that regulates lipid synthesis and 
nailing down these genes would provide a more adequat  knowledge about the right 
target for the discovery of lipid-related diseases medicine.  The TG attenuating effect 
of T3 in both in vivo and in vitro in this study provides a novel data about the new TG 




Chapter 1: In vitro and in vivo attenuation of triglyceride accumulation by tocotrienol  
Part 2. γ-Tocotrienol Attenuates Triglyceride through Effect on Lipogenic Gene 
Expressions in Mouse Hepatocellular Carcinoma Hepa1-6 
 
1.2. Materials and methods 
 
1.2.1 Cell culture 
 
    Hepa 1-6 cells were obtained from the RIKEN cell bank (Tsukuba, Japan).  The 
cells were cultured in DMEM medium (containing 0.3 g/L L-glutamine and 2.0 g/L 
sodium bicarbonate (St. Louis, MO, USA) supplemented with 10% fetal bovine serum 
(FBS; Biowest), 100 kU/L penicillin, and 100 mg/L streptomycin (Gibco) at 37 °C in 
5% CO2/95% air atmosphere in a humidified incubator. 
 
1.2.2 Preparation of experimental medium   
 
    γ-T3 was purchased from Chromadex (Santa Ana, CA, USA), and dissolved in 
ethanol at a concentration of 50 µM.  The stock solution was diluted with10% 
FBS/DMEM medium to achieve the desired final concentration of γ-T3 (0-50 µM).  
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The final concentration of ethanol in the experimental medium was less than 0.1% (v/v), 
which did not affect cell viability.  Medium with ethanol alone was similarly prepared 
and used as control medium. 
 
1.2.3 Cell viability assay 
 
    For cell viability assay, Hepa 1-6cells (1 × 105) were pre-incubated with 10% 
FBS/DMEM in 96 well culture plates.  Twenty-four hours later, the cells were washed 
with PBS and medium was replaced with the experimental medium supplemented with 
or without γ-T3. After incubation for 24 h, the number of viable cells was determined 
using WST-1 reagent (Dojindo Laboratories) according to the manufacturer’s 
instructions.  In brief, WST-1 reagent (10 µL) was added to the medium, and incubated 
at 37 °C for 3 h.  Absorbance (450/655 nm) of the medium was measured with a 
microplate reader (Model 550, Bio-Rad Laboratories, Inc.).  WST-1 is a tetrazolium 
salt that is converted into the soluble formazan salt by succinate-tetrazoliumreductase of 





1.2.4 Lipid analysis   
 
    Cellular lipid and protein concentrations were m asured as follows: Hepa 1-6 (1 × 
105) were incubated with experimental medium in a 35 mm cell culture plate.  After24 
h incubation, cells were washed with PBS, scrapped using rubber policeman, transferred 
onto eppendorf tube, and centrifuged for 1,000 g for 3 min. Cell pellets were transferred 
to micro smashing tube with the addition of 500µLPBS. After homogenization, contents 
of the cellular protein were determined using Bradfor  protein assay (Bio-Rad 
Laboratories). Cellular TG and Cho were extracted using Folch method [32] and were 
measured using commercial kit (Wako). 
 
1.2.5 mRNA analysis 
 
    For real-time quantitative reverse transcription-PCR (RT-PCR) analysis, after 24 h 
treatment of Hepa 1-6 (1 × 105) with the experimental medium, cells were lysed, 
scrapped with rubber police man, and homogenized. Total RNA was isolated from cell 
homogenate with an RNeasy Plus Mini kit (Qiagen). cDNA was synthesized using a 
Ready-To-Go T-Primed First-Strand kit (GE Healthcare), and PCR amplification was 
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performed with a CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories) 
using SYBR Premix Ex Taq (Takara Bio Inc., Shiga, Japan) and gene-specific primers 
for fatty acid synthase (Fasn), sterol regulatory element-binding transcription factor 
1(Srebf1), stearoyl CoA desaturase 1 (Scd1), carnitinepalmitoyltransferase 1A (Cpt1a) 
and β-actin. PCR conditions were 95 °C for 60 s, 95 °C for 5 s, and 65 °C for 30 s for 
40 cycles. 
 
1.2.6 Statistical analysis 
 
    The data were expressed as the mean ± standard deviation (SD).  One-Way 
ANOVA was performed, followed by the Bonferroni/Dunn test for multiple 









1.2.7 Results and discussion 
 
1.2.7.1 Effect of γ-T3 on Hepa 1-6 cells Proliferation 
 
    Hepa 1-6 cells are adherent and epithelial cells growing as monolayer.  This 
mouse hepatoma cell line was derived from the BW7756 tumor that arose in a C57L 
mouse.  The cells secrete several liver-specific products (e.g. albumin, 
alpha1-antitrypsin, alpha-fetoprotein, and amylase), and are used by researchers as a 
good model of lipid metabolism related experiments [44]. 
    We first evaluated the cytotoxicity of γ-T3 to Hepa 1-6 by using WST-1 reagent.  
Hepa 1-6 showed a somewhat increase in cell prolifeat on by γ-T3 treatment (1-15 µM) 
(Fig. 7).  The reasons of the induced cellular proliferation still remain unknown, but 
such increased proliferation was found when cells were incubated with certain 
antioxidants such as catechin [38].Higher dose of γ-T3 (30-50 µM) caused cytotoxic 
effect possibly due to apoptosis induction, as some papers have already reported 
[36].Since 1-15 µM γ-T3 showed no cytotoxicity, experiments for TG and Cho levels 














































Fig. 7 Effect of increasing concentrations of γ-T3 on cell proliferation. Cell proliferation 










1.2.7.2 Effect of T3 on TG and Cho accumulations on Hepa 1-6 cells 
 
    Cellular TG and Cho were extracted by Folch procedure [32], and measured by 
enzymatic methods. 1-5 µM γ-T3 showed no significant differences for TG 
concentrations; however, it was found that 10-15µM γ-T3 revealed a significant 
decrease in TG levels (Fig. 8A). The results were in concordance with our previous 
findings of the TG-lowering effect of T3 in HepG2 cells [45].As for the Cho, no 
significant differences were observed among all the concentrations of γ-T3 (Figs. 8B).  
As mentioned in the introductory paragraphs, current ports have elucidated the 
inhibitory effect of T3 on lipid accumulation with common emphasis to Cho [17].  
However, it should be noted that some reports showed no attenuation of Cho by T3 
[25].Thus, the present findings imply the possibility that the lipid-lowering effect of T3 
might be primary mediated by the reduction of TG rather than Cho. The possibility 
requires further investigation, since TG and Cho are one of the two most abundant lipids 
in the biological system and attenuation of these two lipid classes would be a great 
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Fig. 8 Effect of increasing concentrations of γ-T3 on lipids levels and mRNA 
expressions.  A. TG.  B. Cho.  C. Fasn gene. D. Cpt1a gene.  E. Srebf1 gene.  F. 
Scd1 gene.  Data are expressed as mean ± SD (n = 3).  Means without a common 





1.2.7.3 Effect of T3 on Hepa 1-6 cells lipogenic genes 
 
    To evaluate the mechanisms underlying the TG-lowering effect of γ-T3, we next 
investigated mRNA expression levels of known lipogenic and β-oxidation genes namely 
Fasn, Srebf1, Scd1, and Cpt1a.  Like our previous study using HepG2 cells [45], 
significant down regulation of Fasn and up regulation of Cpt1a genes were observed in 
10-15 µM γ-T3-treated Hepa 1-6 (Figs. 8 C-D).  In addition, we found down 
regulation of Srebf1and Scd1 (Figs. 8 E-F), which are some of the key genes for lipid 
metabolism.  Interestingly, Scd1, a gene that catalyzes a rate-limiting step in the 
synthesis of unsaturated fatty acids, was first suggested in our present study to be down 
regulated by γ-T3. Therefore, the regulation of these lipogenic genes (Fasn, Srebf1, 
Scd1,Cpt1a) might be the possible mechanisms of the TG-lowering effect of γ-T3in 










    In this study, among T3 isomers, effect of γ-T3on TG levels and lipogenic gene 
expressions in Hepa1-6 was evaluated. This is becaus  the isomer is suggested to be 
potent in the regulation of lipid metabolism [29]. Another reason is that the isomer is 
abundant in natural sources such as rice bran [3].  Now, we are comparing the effect of 
T3 isomers using several cells (e.g., Hepa1-6, HepG2, and 3T3-L1 cells), and initially 
found that γ-T3 and δ-T3 showed potent effects on TG levels.  These results will be 
presented in the near future as a different study. 
    In conclusion, γ-T3 showed attenuation of TG through effect on Fasn, Srebf1, Scd1, 
and Cpt1a genes expression in Hepa 1-6.  The result expanded our previous finding of 
lipids-lowering effect of T3, especially TG.  The lipid biosynthesis has a multiple 
interplaying genes that work together to maintain the lipid homeostasis in the biological 
system and aberration of its cellular environment would cause dramatic change of the 
expression of these genes which will led to lipid related afflictions. Therefore, 
understanding the complexity of lipid biosynthesis at gene expression level is of vital 
importance for the development of natural product medicine (e.g., T3) against lipid 
related diseases.  Consequently, further studies pertaining to the lipid-lowering effect 
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and mechanism of T3 is recommended to provide ample evidences for a realistic 
prospect of its use as a human therapy. 
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Modulation of tocotrienol to crucial lipid metabolism-related 












Introduction and objective 
 
   According to the world health organization (WHO), a change in lifestyle and habits 
which contributes to a change in dietary patterns have increased in the generation of 
lifestyle related diseases especially those closely linked to heart, liver, obesity and other 
metabolic-related afflictions. Moreover, obesity in particular has become more prevalent 
in a certain social strata [46]. Though several approaches have been done regarding the 
amelioration of obesity, most of these undertakings largely unsuccessful. Several 
experimental trials concerning molecular regulation of some known lipid species such 
as triglyceride (TG) and cholesterol (Cho) via biologically active molecules are in route 
to reduce abnormal lipid accumulations. 
   The fat homeostasis is characterized between fat synthesis and fat breakdown in the 
biological system. Metabolic-related diseases such as obesity happen when the balance 
between energy intakes exceeds energy expenditure [47, 48]. Glucose generated from 
carbohydrates stimulates lipogenesis by making it a substrate for lipogenic process 
which is glycolytically converted to acetyl-CoA. This conversion then provides an 
ample substrate (acetyl-CoA) to be carboxylated by acetyl-CoA carboxylase (ACC) to 
malonyl-CoA of which it is elongated by fatty acid synthase (FAS) to create fatty acids 
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of dependent types. Regulation of this complex interplay would consequently affect fat 
storage potential. 
   Since the discovery of adipose tissue as one of the sites that could synthesize fatty 
acids [49], this led to the initial conclusion that this tissue is the major site for 
lipogenesis. Therefore, understanding the cellular mechanisms involved in the 
aberration of the homeostatic status of fat storage and usage in the adipose tissue could 
entail an array of new insights regarding the possibility of future pharmacological target 
for the treatment of obesity and other metabolic-related diseases. 
   Recently, a handful of studies have been reported concerning the novel utilization of 
functional food components and nutrients as possible inhibitory agent against 
endogenous lipid accumulation generated by aberrant lipid metabolic process. For 
instance, catechin has been reported to inhibit adipocyte differentiation via down 
regulation of peroxisome proliferator-activated receptor (PPAR)-γ and 
CCAAT/enhancer binding protein (C/EBP)-α in 3T3-L1 cells [50].Furthermore, 
administration of carotenoids and retinoids has been linked to have anti-adiposity 
through nuclear receptors regulation [51]. 
   T3 has recently gained increasing interest due to its several health-promoting 
properties that differ somewhat from those of Toc. For example, T3 protects neuronal 
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cells against oxidative damage, and have anti-angiogenesis, anti-tumor, and 
lipid-lowering activity [22, 5, 6, 7, 8, and 45]. However, it should be noted that only few 
paper have been published focusing on the biological effect of T3 on lipogenesis in the 
adipose tissue. T3 is reported to suppress adipocyte insulin-induced differentiation and 
Akt phosphorylation in 3T3-L1 preadipocytes [52]. It was also cited that γ-T3 isomer 
may improve obesity-related functional abnormalities in adipocytes by attenuating 
nuclear factor (NF)-κB activation and the expression of inflammatory adipok nes 
[53].Though these data emphasized the potency of T3 as anti-adipogenic and 
anti-inflammatory agents in adipocyte cells, it is al o worth to note that the lipid 
metabolic pathway is very complex as such regulation only of those genes (NF-κB and 
inflammatory adipokines) would not confirm the clinical usage of T3 as future 
anti-metabolic disease medicine. Because of the scarcity of data concerning the impact 
of T3 as potential lipid metabolism regulator in adipose tissues, further biological 
studies are needed to elucidate the mechanisms involve on how T3 affects the 
interaction of crucial genes in the lipid metabolism pathway in adipocyte cells. In this 
study, investigations concerning the modulation of T3 on lipid metabolism via multiple 
metabolic genes regulation in 3T3-L1 differentiated preadipocytes were clearly 
elucidated trough cellular, RT-PCR and western blotting analyses respectively. 
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Chapter 2: Modulation of tocotrienol to crucial lipid metabolism-related genes in 
3T3-L1 differentiated cell lines. 
 
2. Materials and methods 
 
2.1. Reagents and cells 
 
   T3 isomers and α-Toc were kindly provided by Eisai Food & Chemical Co., Ltd 
(Tokyo, Japan) and were dissolved in ethanol at a concentration of 50 mM as stock 
solution. 3T3-L1 preadipocytes were obtained from the RIKEN cell bank (Tsukuba, 
Japan).The cells were cultured in DMEM medium (high glucose; Sigma, St. Louis, MO) 
containing 0.3 g/L L-glutamine and 2.0 g/L sodium bicarbonate supplemented with 10% 
fetal bovine serum (FBS; Biowest), 100 kU/L penicillin, and 100 mg/L streptomycin 
(Gibco BRL) at 37 °C in 5% CO2/95% air atmosphere in a humidified incubator. All 







2.2. Preparation of experimental medium for cell culture study 
 
   T3 isomers and α-Toc stock solutions were diluted with10% FBS/DMEM (high 
glucose) medium to achieve the desired final concentration (0-50 µM). The final 
concentration of ethanol in the experimental medium was less than 0.1% (v/v), which 
did not affect cell viability. Medium with ethanol a one was similarly prepared and used 
as control medium. 
 
2.3. Cell viability assay 
 
   For cell viability assays, 3T3-L1preadipocytes (2 × 104) were pre-incubated with 
10% FBS/DMEM (high glucose) in 96 well culture plates. 24 h later, the cells were 
washed with phosphate buffered saline (PBS) and mediu  was replaced with the 
experimental medium. After incubation for 24 h, thenumber of viable cells was 
determined using WST-1 reagent according to the manufacturer’s instructions (Dojindo 
Laboratories).In brief, WST-1 reagent (10 µL) was added to the medium, and incubated 
at 37 °C for 3 h. Absorbance (450/655 nm) of the medium was measured with a 
microplate reader (Model 550, Bio-Rad Laboratories). 
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2.4. Adipocyte differentiation 
 
   3T3-L1 preadipocytes (2 × 104) were seeded in a 35 mm cell culture plates 
supplemented with 10%FBS/DMEM (high glucose), and incubated for 3 d. 
Differentiation was then initiated by 10%FBS/DMEM(hig  glucose) containing 0.25 
µM dexamethasone, 0.5 mM 3-isobuthyl-1-methylxanthine a d 10 µg/mL insulin in the 
presence or absence of T3 isomers and α-Toc. The cells were then further incubated for 
6-8 din 10%FBS/DMEM (high glucose) containing only 10 µg/mL insulin at 2 d 
interval from the start of the differentiation. 
 
2.5. TG analysis 
 
   Cellular TG concentrations were evaluated using Folch method [32]. Briefly, 
3T3-L1 (2× 104) preadipocytes were washed with PBS and scrapped using rubber 
policeman, transferred into eppendorf tube (1.5 mL)and were centrifuged for 1000 g for 
3 min. Cell pellets were transferred to micro smashing tube with the addition of 500 µL 
PBS buffer for homogenization. After homogenization, contents of the cellular protein 
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were determined using Bradford protein assay [33]. Cellular TG was measured using 
commercial TG kit (Wako). 
 
2.6. Oil red O staining 
 
   Differentiated 3T3-L1 preadipocytes were washed with PBS and were fixed using 
4% formalin for 60 min. After fixation, the cells were washed with distilled water, 
stained with filtered oil red O working solution and washed further with distilled water. 
Visualization of the stained lipids was performed using photomicrograph system. 
 
2.7. Isolation of total RNA and analysis of mRNA expression 
  
  Total cellular RNA was isolated with an RNeasyPlus Mini kit (Qiagen) for real-time 
quantitative reverse transcription-PCR (RT-PCR). cDNA was synthesized using a 
Ready-To-Go T-Primed First-Strand kit (GE Healthcare), and PCR amplification was 
performed with a CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories) 
using SYBR Premix Ex Taq (Takara Bio Inc.) and gene-sp cific primers for FAS, 
carnitine palmitoyltransferase I(CPT1), stearoyl-CoA desaturase 1(SCD-1),acetyl-CoA 
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carboxylase 1 (ACC1), sterol regulatory element-binding protein 1c (SREBP 
1c),adiponectin receptor 2 (ADIPOR2), uncoupling protein 2 (UCP2), 
3-hydroxy-3-methyl-glutaryl-CoA reductase (HMG-CoA-R), low-density lipoprotein 
receptor (LDLR),PPAR-γ, and beta actin (β-actin). PCR conditions were 95 °C for 60 s, 
95 °C for 5 s, and 65 °C for 30 s for 40 cycles. 
 
2.8. Western blotting analysis 
 
   Differentiated 3T3-L1 preadipocytes proteins were xtracted and separated by 
SDS-PAGE (4-20% e-PAGEL; Atto). The protein bands were transferred to 
polyvinylidene fluoride membranes (Invitrogen).After blocking for 1 h, membranes 
were incubated with primary antibodies for FAS,CPT1, SCD-1, ACC1, SREBP 1c, 
UCP2, LDLR, PPAR-γ, and β-actin (Cell Signaling Technology, followed by 
horseradish peroxidase-conjugated secondary antibody (Cell Signaling 
Technology).ECL Plus (GE healthcare) was used for detection. Bands intensities were 





2.9 Statistical analysis 
  
  The data were expressed as the mean ± standard deviation (SD). One-Way ANOVA 
was performed, followed by the Bonferroni/Dunn test for multiple comparisons. 
















2.10 Results and discussion 
 
2.10.1 Treatment of T3, especially δ and γ isomers, inhibits TG and lipid droplets 
accumulations in differentiated 3T3-L1 preadipocytes 
 
   First of all, sample treated 3T3-L1 preadipocytes were subjected to WST-1 assay. 
Results showed that most of the T3 isomers exhibited cytotoxic effect to 3T3-L1 
preadipocytes at higher doses (20-50 µM) except that of α-T3 which only showed 
significant cytotoxicity at 50 µM (Fig. 9). However, α-Toc did not show any cytotoxic 
effect to 3T3-L1 preadipocytes. As to the reason why α-Toc did not show any cytotoxic 
effect to the cells is still unknown. But such manifestation has been observed in 
different cell lines such as human hepatocellular carcinoma (HepG2) [45]Since most of 
the T3 isomers showed less cytotoxic effect at 25 µM, this concentration was used in the 
succeeding experiments. 
   Next, 3T3-L1 differentiated preadipocytes were trea ed with T3 or Toc for 8 d, and 
cellular TG was extracted. TG levels were measured sing TG measuring Kit (Wako), 
and expressed as mg/mg protein. T3 showed abrogation of TG in differentiated 
preadipocytes at dose dependent manner (Fig. 10). T3 isomers (δ-, γ-, and β-T3) 
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attenuated TG levels at 25-50 µM concentrations, but α-T3 showed attenuation only 
at50 µM. Structurally, α-T3has 5- and 7-methyl groups attached to its chroman ring, so 
it is possible that α-T3 could hardly pass through cell membranes. The poor
incorporation of α-T3 into 3T3-L1 differentiated preadipocytes may explain its lower 
inhibitory effect on cellular TG levels. To date, fw data have shown the ability of some 
T3 isomers such as γ- and α-T3 in the reduction of cellular TG in adipocyte cell lines 
[52], but however it is also important to note that α-Toc failed to show significant TG 
attenuation (Fig. 10). Our findings provided a new information regarding the effect of 













































































































































































































































Fig. 10 Effect of increasing concentrations of T3 or α-Toc (0-50µM) on TG levels of 
differentiated 3T3-L1 preadipocytes at 8 d after differentiation. Experimental 
procedures are shown in Materials and methods. Data are expressed as mean ± SD (n = 










   In order to confirm whether T3 or Toc affects the lipid droplets accumulation in 
3T3-L1 differentiated preadipocytes, oil red O staining technique was performed. 
Cellular lipid droplets aggregations were significantly observed from 6 to 8 d after 
differentiation (Fig. 11). Differentiated preadipocytes treated with T3 showed 
significant reduction of lipid droplets with higher ffect exhibited by δ-, γ-, and β-T3 
isomers respectively. Though α-T3 also showed a less reduction of lipid droplets, its 
effect was comparable with other T3 isomers. Moreover, α-Toc did not showed any 
observable reduction of lipid droplets in the differentiated preadipocytes. In its simplest 
form, lipid droplets controls the storage and hydrolysis of neutral lipids including TG or 
Cho esters and its regulation is of vital importance in the development of lipid-related 
diseases [54]. Therefore, T3, but not Toc, may attenuate TG accumulation by reducing 





































Fig. 11 Oil red O stained lipid droplets of differentiated 3T3-L1 preadipocytes treated 
with T3 or α-Toc (25 µM) from 0, 6, and 8 d after differentiation. Scale bar= 30 µm. 




2.10.2. Regulation of T3 to crucial lipid metabolism-related genes and proteins in 
3T3-L1 differentiated preadipocytes 
 
   Effects of T3 or Toc on mRNA expression levels of me known crucial lipogenic 
genes were investigated. Differentiated 3T3-L1 preadipocytes treated with or without 
T3 or Toc at 8 d after differentiation were harvested and subjected to mRNA extraction. 
Selected genes mRNA expressions were evaluated using RT-PCR. Expression of crucial 
lipid metabolism-related genes such as FAS, SCD-1, ACC1, SREBP 1c, LDLR, and 
PPAR-γ were significantly down regulated by δ- and γ-T3 (Fig. 12). On the other hand, 
β-T3 showed down regulation to SCD-1, ACC1 and LDLR genes respectively. There 
were no significant attenuation observed for α-T3 and α-Toc. In contrast, only δ- and 
γ-T3 significantly up-regulated CPT1, ADIPOR2 and UCP2 genes expressions (Fig.12).             
FAS and SREBPs are both noted to be the culprit of lipid synthesis and regulation of 
these genes are known to induce dramatic reductions of fat accumulations [55, 56]. 
Moreover, reports showed that SCD-1 inhibition results in the buildup of acyl-CoAs 
which in turn cause a feedback suppression to ACC. This cascading reaction then 
diminishes the inhibition of CPT shuttle and will al ow fat transportation to the 
mitochondria for breakdown via β-oxidation [57, 58]. In this study, interestingly, gene 
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that codes for Cho synthesis (HMG-CoA-R) was not regulated by all experimental 
groups. This observation was in coherence with our previous animal and cell culture 
studies [45]. We therefore then hypothesize that the reported lipid lowering effect of T3 
might be mediated by its regulation to other crucial lipid metabolism-related genes 
rather than HMG-CoA-R gene. The present study caters an immense possibility that T3 






























Fig. 12 Effect of T3 or α-Toc (25 µM) on mRNA expression of FAS, CPT1, SCD-1, 
ACC1, SREBP 1c, ADIPOR2, UCP2, HMG-CoA-R, LDLR, and PPAR-γ genes in 
differentiated 3T3-L1 preadipocytes at 8 d after differentiation. Data are expressed as 
mean ± SD (n = 3). Means without a common letter differ, P< 0.05. 
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   Finally, we extracted the proteins from differentiated 3T3-L1 preadipocytes 
incubated with T3 and Toc for 8 d, and analyzed the proteins using customary western 
blotting procedure. Protein blots revealed that δ- and γ-T3 markedly repressed FAS, 
SCD-1, ACC1, SREBP 1c, LDLR, and PPAR-γ protein expressions (Fig. 13). Up 
regulation of CPT1 and UCP2 proteins were also observed in δ- and γ-T3 treated 
3T3-L1 differentiated preadipocytes. However, β-T3 did not showed remarkable 
regulation to all selected proteins though it displayed significant mRNA regulation to 
SCD-1, ACC1, and LDLR genes (Fig. 12). This might employ that the effect of β-T3 to 
these genes is confined only at mRNA level. This obervation may relate to the 
processes between transcription and translation regulation. The correlation between 
transcription and translation level can vary sometis as there are many steps and 
factors involved in the two processes. An mRNA may h ve a low expression profile, but 
may be stable and efficiently translated. In the present study, both α-T3 and α-Toc did 
not show any significant regulation to all the proteins (Fig. 13). This is the first data 
reported concerning the wide regulation of T3 to crucial lipid metabolism-related 
protein expressions in differentiated preadipocytes. The modulation of T3 to these 
crucial lipid metabolism-related proteins accentuates the possible reason as to the 









































































































































































































Furthermore, the underlying mechanism on how T3 (especially δ and γ isomers) 
significantly regulated both mRNA and protein expressions of crucial lipid 
metabolism-related genes can somehow be explained on its individual isomer molecular 
structure differences. This assumption has been currently in experimental development 
in our laboratory. Generally, adhering to these valuab e findings, regulation of T3 on 
both mRNA and protein expressions of lipid metabolism related-genes would create a 
possible down and upstream modulation of interacting genes necessary for lipid 
metabolism which eventually could lead to the ameliorat on of lipid metabolism-related 
diseases. A thorough study on how these regulated genes by T3 affects the other 
interplaying genes necessary for the total cellular process of lipid metabolism are of 












   The present study elucidated information as to the effect of T3 on lipid 
metabolism-related genes and proteins in differentiated 3T3-L1 preadipocytes. Among 
all the T3 isomers, δ-, γ- and β-T3 showed a marked significance in attenuating cellular 
TG levels in differentiated 3T3-L1 preadipocytes by modulating the gene and protein 
expressions concerning lipid metabolism. β-T3 on the other hand showed only 
significant modulation to selected lipid metabolism related genes mRNA expression, but 
failed to show modulation in its protein expression. This peculiarity is hypothesized 
that β-T3 effect on these genes was confined only at mRNA level. In the current 
experimental condition, gene concerning Cho synthesis (HMG-CoA-R) was not 
regulated by T3 or Toc. Both α-T3 and α-Toc did not demonstrate any significant 
regulation to TG level, mRNA and protein expression f lipid metabolism-related 
genes. Up to present, there were only very few data reporting the potency of T3 to 
regulate lipid metabolism related genes in 3T3-L1 preadipocytes[52, 53] as such the 
present study provided a new set of evidences concerni g the possibility of T3 as an 











 γ and δ Tocotrienol suppresses hepatocellular liver carcinoma 
cell line proliferation via proto-oncogene Ras- associated 











Introduction and objective 
  T3 has recently gained increasing interest due to its several health-promoting 
properties that differ somewhat from those of Toc.  Reports stated that T3 protects 
suppresses pathological angiogenesis, and cancer [7, 8]. These unique effects of T3 
could be partly explained by its abilities to induce ell cycle arrest [9], to activate p53 
and caspase [10,11]. Most of these mechanisms were considerably associated to the 
regulation of Ras-Raf-MEK-ERK oncogenic pathway. 
  Within the context of these effects regarding mechanism of T3 against cancer, it 
should be noted that there were a handful of information regarding the effect of T3 in 
the upstream signaling of this oncogenic pathway. Since the immense effect of T3 on 
Ras-Raf-MEK-ERK oncogenic pathway has been the crucial regulatory factor for this 
oncogenic pathway cascades, it is worth speculating that these manifestations might be 
first at hand being ubiquitously regulated by its upstream associated signaling process. 
In this study, we investigated whether T3 suppresses Human hepatocellular carcinoma 
cell line proliferation via regulation of Ras-associated upstream signaling gene and 
protein expressions. These data will be of vital importance in the elucidation of the 
regulatory potential of T3 on Ras-Raf-MEK-ERK oncogenic pathway which may in turn 
gives tangible information as to the application of T3 for clinical benefits. 
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Chapter 3: γ and δ  Tocotrienol suppresses hepatocellular liver carcinoma cell line 
proliferation via proto-oncogene Ras- associated upstream signaling regulation 
 
3.  Materials and methods 
 
3.1 Reagents and cells 
 
   γ and δ T3 isomers were kindly provided by Eisai Food & Chemical Co., Ltd and 
were dissolved in ethanol at a concentration of 50 mM as stock solution. HepG2 cells 
were obtained from the RIKEN cell bank (Tsukuba, Japan). The cells were cultured in 
RPMI/1640 medium (containing 0.3 g/L L-glutamine and 2.0 g/L sodium bicarbonate 
(St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS; Biowest), 100 
kU/L penicillin, and 100 mg/L streptomycin (Gibco BRL) at 37 °C in 5% CO2/95% air 
atmosphere in a humidified incubator. All reagents used in this study were of analytical 
grade. 





3.2 Preparation of experimental medium  
 
   γ and δ T3 isomers stock solutions were diluted with10% FBS/RPMI-1640 medium 
to achieve the desired final concentration (0-50 µM).  The final concentration of 
ethanol in the experimental medium was less than 0.1% (v/v), which did not affect cell 
viability.  Medium with ethanol alone was similarly prepared and used as control 
medium. 
 
3.3 Cell proliferation assay 
 
   For cell viability assays, HegG2 cells (1 × 105) were pre-incubated with 10% 
FBS/RPMI-1640 in 96 well culture plates.  Twenty-four hours later, the cells were 
washed with PBS and medium was replaced with the experimental medium.  After 
incubation for 24 h, the number of viable cells was determined using WST-1 reagent 
according to the manufacturer’s instructions.  In brief, WST-1 reagent (10 µL) was 
added to the medium, and incubated at 37 °C for 3 h.  Absorbance (450/655 nm) of the 




3.4 Isolation of total RNA and analysis of mRNA expression 
 
   Total cellular RNA was isolated with an RNeasyPlus Mini kit (Qiagen) for real-time 
quantitative reverse transcription-PCR (RT-PCR).  cDNA was synthesized using a 
Ready-To-Go T-Primed First-Strand kit (GE Healthcare), and PCR amplification was 
performed with a CFX96 Real-Time PCR Detection System (Bio-Rad Laboratories,) 
using SYBR Premix Ex Taq (Takara Bio Inc.) and gene-sp cific primers for GTPase 
Hras (Hras), growth factor receptor-bound protein 2 (Grb2), son of sevenless homolog,  
1 (Sos-1), phospho proto-oncogene c-Src family (Phospho-Src Tyr416), phospho-Shc 
(Phospho-Shc Tyr 239/240) and beta actin (β-actin). PCR conditions were 95 °C for 60 
s, 95 °C for 5 s, and 65 °C for 30 s for 40 cycles. 
 
3.5 Western Blotting Analysis 
 
   After HepG2 (1 × 105) cells were incubated with test medium for 24 h, proteins 
were separated by SDS-PAGE (4-20% e-PAGEL; Atto).  The protein bands were 
transferred to polyvinylidene fluoride membranes (Invitrogen).  After blocking for 1 h, 
membranes were incubated with primary antibodies for Hras, Grb2, Sos-1, Phospho-Src. 
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Phospho-Shc and β-actin (Cell Signaling Technology, Beverly, MA, USA), followed by 
horseradish peroxidase-conjugated secondary antibody (Cell Signaling Technology).  
ECL Plus (GE healthcare) was used for detection.  Bands intensities were measured 
using Image Lab software version 3.0 (BioRad). 
 
3.6 Statistical analysis  
 
   The data were expressed as the mean ± standard deviation (SD).  One-Way 
ANOVA was performed, followed by the Bonferroni/Dunn test for multiple 











3.7 Results and discussion 
 
3.7.1 Effect of γ and δ T3 on HepG2 Proliferation 
 
   Cytotoxic activity of both γ and δ T3 including α-Toc were first evaluated. HepG2 
proliferation was significantly inhibited at higher dose of T3 (15-50 µM) at dose 
dependent manner. Among all the T3 isomers (γ and δ ) concentrations, significant 
inhibition of HepG2 cells proliferation were already observed at 15 µM. However, 
α-Toc did not show any significant inhibitory effect to HepG2 cells at all concentrations 
(Fig.14). Since both T3 isomers showed significant inhibitory effect to HepG2 at 15 µM, 






















Fig. 14 Effect of increasing concentrations of γ and δ T3 including α- Toc on HepG2 
cell proliferation. Cell proliferation data are expressed as mean ± SD (n = 6).  Means 







3.7.2 γ and δ T3 regulated proto-oncogene Hras and  Ras- associated upstream 
signaling genes expressions 
 
   γ and δ T3 treatment to hepatocellular carcinoma cells showed significant cytotoxic 
effect at higher dose (15-50 µM δ and γ T3 concentrations). Down regulation of 
proto-oncogene Hras gene expressions was significantly observed in HepG2 cells for 
both T3 isomers. Additionally, Ras upstream genes signaling cohorts (Grb2, Sos-1, 
Phospho-Src Tyr41 and Phospho-Shc Tyr 239/240) were also significantly down 
regulated upon administration of both γ and δT3 isomers at dose dependent manner 





























Fig. 15 Effects of γ-T3 (0-20 µM) on mRNA expressions of Hras, Grb2, Sos-1, 
Phos-Src and Phos-Shc genes in HepG2. Data are expressed as mean ± SD (n= 3). 






















Fig. 16 Effects of δ-T3 (0-20 µM) on mRNA expressions of Hras, Grb2, Sos-1, 
Phos-Src and Phos-Shc genes in HepG2. Data are expressed as mean ± SD (n= 3). 




  3.7.2 γ and δ T3 regulated proto-oncogene Hras and Ras- associated upstream 
protein expressions 
  
   Proto-oncogene Hras and its Ras-associated upstream signaling genes protein 
expressions were measured via western blotting analysis. γ and δ T3 showed marked 
down regulation of Hras, Grb2, Sos-1, Phos-SRC and Phos Shc protein expressions at 
dose dependent manner (Figs. 17&18).  
   Therefore, the current findings demonstrated a novel mechanism of the anti-cancer 
effect of T3 specifically γ and δ  T3 isomers via proto-oncogene Ras upstream signaling 
regulation. Furthermore, since Ras activation directly influences the activity of 
Ras-Raf-MEK-ERK oncogenic pathway, it is then hypothesized that the reported 
anti-cancer mechanisms of T3 via Ras-Raf-MEK-ERK pathw y oncogenic cascades to 

































Fig. 17 Effects of γ-T3 (0-20 µM) on protein expressions of Hras, Grb2, Sos-1, 
Phos-Src and Phos-Shc genes in HepG2. Each western blot is a representative 





























Fig. 18 Effects of δ-T3 (0-20 µM) on protein expressions of Hras, Grb2, Sos-1, 
Phos-Src and Phos-Shc genes in HepG2. Each western blot is a representative 






   The cytotoxic effect of T3 to various cancer cell lines is very valuable information. 
The major scientific claims regarding its mechanisms on cancer regulation were mainly 
focused on its ability to affect some major molecular oncogenic pathways (AKT 
signaling, EGF pathways, p53 pathways, etc) [7]. Because of the complexity of the 
cancer signaling process, it is of vital importance to perform an expansive research 
pertaining to the effect of T3 on different genes that are interacting with these pathways. 
For instance, Ras genes are one of the key switch genes for cancer progression in 
Ras-Raf-MEK-ERK oncogenic pathway that is crucial in the regulation f cellular 
proliferation process in response to growth factor stimulation [59]. Interestingly, our 
present in vitro data showed that T3 specifically δ and γ T3 significantly regulated the 
mRNA and protein expressions of Hras gene; one of the isoforms of Ras gene family in 
human hepatocellular carcinoma cell line. Moreover,  γ and δ T3 also markedly 
regulated the Hras-associated upstream signaling genes. Since Ras activation directly 
influences the activity of Ras-Raf-MEK-ERK oncogenic pathway, it is then 
hypothesized that the reported anti-cancer mechanisms of T3 via Ras-Raf-MEK-ERK 
pathway oncogenic cascades to various cancer cell lin s might be mediated by the 
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   T3 as one of the groups of a naturally-occurring vitamin E family has been 
considerably attracted the attention of some research scientists due its promising 
biological activity that may even surpass its potency to Toc, the most commonly known 
and studied vitamin E group. One of the recently dynamic researches on T3 was focused 
on its lipid metabolism and cancer regulations. In our studies, we found out a series of 
novel functions and mechanisms of T3 on lipid metabolism regulation [45]. Both in 
vitro and in vivo experimental data suggested that T3 affects lipid accumulation by 
multiple regulations of lipid metabolism-related genes. Moreover, the ability of T3 to 
reduce oxidative stress due to fat-induced oxidative damage has been a crucial factor to 
its total novel biological function against lipid accumulation. Aberrant lipid metabolic 
process could generate multiple diseases that are linked to obesity and other 
metabolic-related diseases. Therefore, understanding the cellular mechanisms involve in 
the aberration of the homeostatic status of fat storage and usage in the biological 
systems and nailing down this pathological signaling abnormalities could entail an array 
of new insights regarding the possibility of future pharmacological target for the 
treatment of obesity and other metabolic-related diseases. 
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  Besides this novel bioactivity rendered by T3, it is also very important to note 
that T3 has been reported to display a remarkable cytotoxic effect to various cancer cell 
lines. The major scientific claims regarding its mechanisms on cancer regulation were 
mainly focused on its ability to affect some major molecular oncogenic pathways (AKT 
signaling, EGF pathways, p53 pathways, etc) [7]. Because of the complexity of the 
cancer signaling process, it is of vital importance to perform an expansive research 
pertaining to the effect of T3 on different genes that are interacting with these pathways. 
For instance, Ras genes are one of the key switch genes for cancer progression in 
Ras-Raf-MEK-ERK oncogenic pathway that is crucial in the regulation f cellular 
proliferation process in response to growth factor stimulation [59]. Interestingly, our 
present in vitro data showed that T3 specifically γ and δ T3 significantly regulated the 
mRNA and protein expressions of Hras gene; one of the isoforms of Ras gene family in 
human hepatocellular carcinoma cell line. Moreover, γ and δ T3 also markedly 
regulated the Hras-associated upstream signaling genes. Since Ras activation directly 
influences the activity of Ras-Raf-MEK-ERK oncogenic pathway, it is then 
hypothesized that the reported anti-cancer mechanisms of T3 via Ras-Raf-MEK-ERK 
pathway oncogenic cascades to various cancer cell lin s might be mediated by the 
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Supplementary figure 1. Effect of increasing concentrations of α-Toc on cell 
proliferation (A) and TG accumulation (B) of HepG2 in normal and fat overloaded 
conditions.  Experimental procedures are shown in Materials and Methods.  Data are 
expressed as mean ± SD (n = 6 for cell proliferation and n = 3 for TG accumulation).  
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